Zydus Lifesciences Ltd receives 4 observations from USFDA post inspection at SEZ Onco Injectable site

The USFDA conducted an inspection at the SEZ Onco Injectable manufacturing plant at Ahmedabad. This cGMP USFDA inspection was conducted from March 18th to March 27th, 2024.

The inspection closed with 4 observations. There were no Data Integrity related observations. The Company will closely work with the USFDA to address the observations.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 999.60 as compared to the previous close of Rs. 1018.10. The total number of shares traded during the day was 54387 in over 3043 trades.

The stock hit an intraday high of Rs. 1030.15 and intraday low of 998.05. The net turnover during the day was Rs. 55050952.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Pharmaceuticals USFDA Form483 4Observations SEZ OncoInjectables